Gabapentin is used to treat nerve pain from shingles and to help control certain types of seizures. It's also commonly prescribed to help manage pain and other symptoms related to damaged nerves.[2] Neurontin is currently approved and in use across 69 indications[4].[1]
Neurontin is one of 911 small molecule programs targeting Epilepsy. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
175 competitors in Asthma
Neurontin
Celexa
Arcoxia
Solu-Medrol
DUPIXENT
Blood Withdrawn
Paracetamol
Aclidinium Bromide
Atrovent
Ozone
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Dec 30, 1993
NEURONTIN
NDA NDA020235
Nov 14, 1994
NEURONTIN
NDA NDA020235
Apr 9, 1996
NEURONTIN
NDA NDA020235
May 28, 1996
NEURONTIN
NDA NDA020235
Dec 9, 1996
NEURONTIN
NDA NDA020235
Feb 12, 1998
NEURONTIN
NDA NDA020235
Sep 29, 1998
NEURONTIN
NDA NDA020235
Oct 9, 1998
NEURONTIN
NDA NDA020882
Oct 9, 1998
NEURONTIN
NDA NDA020882
Mar 2, 2000
NEURONTIN
NDA NDA021129
Mar 2, 2000
NEURONTIN
NDA NDA021129
May 15, 2000
NEURONTIN
NDA NDA020235
Jul 21, 2000
NEURONTIN
NDA NDA020235
Aug 16, 2000
NEURONTIN
NDA NDA020235
Sep 19, 2000
NEURONTIN
NDA NDA021129
Sep 19, 2000
NEURONTIN
NDA NDA020882
Oct 12, 2000
NEURONTIN
NDA NDA020882
Oct 12, 2000
NEURONTIN
NDA NDA020235
Oct 12, 2000
NEURONTIN
NDA NDA021129
Jan 18, 2001
NEURONTIN
NDA NDA020235
Feb 8, 2001
NEURONTIN
NDA NDA020235
Feb 8, 2001
NEURONTIN
NDA NDA020235
Apr 26, 2001
NEURONTIN
NDA NDA021129
Jan 18, 2002
NEURONTIN
NDA NDA021129
Jan 18, 2002
NEURONTIN
NDA NDA020235
Jan 18, 2002
NEURONTIN
NDA NDA020882
Jan 30, 2002
NEURONTIN
NDA NDA020235
Jan 30, 2002
NEURONTIN
NDA NDA021129
Jan 30, 2002
NEURONTIN
NDA NDA020882
Aug 15, 2002
NEURONTIN
NDA NDA020882
Aug 15, 2002
NEURONTIN
NDA NDA021129
Aug 15, 2002
NEURONTIN
NDA NDA020235
Oct 24, 2002
NEURONTIN
NDA NDA021129
Oct 24, 2002
NEURONTIN
NDA NDA020882
Oct 24, 2002
NEURONTIN
NDA NDA020235
Dec 19, 2002
NEURONTIN
NDA NDA020235
Dec 19, 2002
NEURONTIN
NDA NDA021129
Dec 19, 2002
NEURONTIN
NDA NDA020882
Apr 30, 2004
NEURONTIN
NDA NDA020882
Feb 18, 2005
NEURONTIN
NDA NDA020882
Feb 18, 2005
NEURONTIN
NDA NDA021129
Feb 18, 2005
NEURONTIN
NDA NDA020235
May 3, 2006
NEURONTIN
NDA NDA020882
May 3, 2006
NEURONTIN
NDA NDA020235
May 3, 2006
NEURONTIN
NDA NDA021129
Apr 23, 2009
NEURONTIN
NDA NDA020882
Apr 23, 2009
NEURONTIN
NDA NDA020235
Apr 23, 2009
NEURONTIN
NDA NDA021129
Nov 20, 2009
NEURONTIN
NDA NDA020235
Oct 11, 2010
NEURONTIN
NDA NDA020882
Oct 11, 2010
NEURONTIN
NDA NDA020235
Oct 11, 2010
NEURONTIN
NDA NDA021129
Jan 28, 2011
GRALISE
NDA NDA022544
Mar 1, 2011
NEURONTIN
NDA NDA020235
Mar 1, 2011
NEURONTIN
NDA NDA021129
Mar 1, 2011
NEURONTIN
NDA NDA020882
Aug 10, 2011
NEURONTIN
NDA NDA020235
Aug 10, 2011
NEURONTIN
NDA NDA020882
Aug 10, 2011
NEURONTIN
NDA NDA021129
May 1, 2013
NEURONTIN
NDA NDA020882
May 1, 2013
NEURONTIN
NDA NDA021129
May 1, 2013
NEURONTIN
NDA NDA021129
May 1, 2013
NEURONTIN
NDA NDA021129
May 1, 2013
NEURONTIN
NDA NDA020235
May 1, 2013
NEURONTIN
NDA NDA020235
May 1, 2013
NEURONTIN
NDA NDA020235
May 1, 2013
NEURONTIN
NDA NDA020882
May 1, 2013
NEURONTIN
NDA NDA020882
Jul 18, 2013
NEURONTIN
NDA NDA021129
Apr 15, 2014
NEURONTIN
NDA NDA021129
Aug 18, 2014
NEURONTIN
NDA NDA021129
Aug 18, 2014
NEURONTIN
NDA NDA020882
Aug 18, 2014
NEURONTIN
NDA NDA020235
Apr 21, 2015
NEURONTIN
NDA NDA021129
Apr 21, 2015
NEURONTIN
NDA NDA020235
Apr 21, 2015
NEURONTIN
NDA NDA020882
Sep 14, 2015
NEURONTIN
NDA NDA021129
Sep 14, 2015
NEURONTIN
NDA NDA020882
Sep 14, 2015
NEURONTIN
NDA NDA020235
Mar 24, 2017
NEURONTIN
NDA NDA020882
Mar 24, 2017
NEURONTIN
NDA NDA021129
Mar 24, 2017
NEURONTIN
NDA NDA020235
Oct 18, 2017
NEURONTIN
NDA NDA020235
Oct 18, 2017
NEURONTIN
NDA NDA021129
Oct 18, 2017
NEURONTIN
NDA NDA020882
Apr 2, 2020
NEURONTIN
NDA NDA020235
Apr 2, 2020
NEURONTIN
NDA NDA020882
Apr 2, 2020
NEURONTIN
NDA NDA021129
Dec 16, 2020
NEURONTIN
NDA NDA020235
Dec 16, 2020
NEURONTIN
NDA NDA020882
Dec 16, 2020
NEURONTIN
NDA NDA021129
Jul 12, 2024
NEURONTIN
NDA NDA020882
Jul 12, 2024
NEURONTIN
NDA NDA020235
Jul 12, 2024
NEURONTIN
NDA NDA021129
Apr 25, 2025
NEURONTIN
NDA NDA020882
Apr 25, 2025
NEURONTIN
NDA NDA021129
Apr 25, 2025
NEURONTIN
NDA NDA020235
Sources
Details